{
    "Trade/Device Name(s)": [
        "EUROIMMUN anti-Proteinase 3 (PR3) ELISA IgG",
        "EUROIMMUN anti-Myeloperoxidase (MPO) ELISA IgG",
        "Anti-Proteinase 3 (PR3) ELISA IgG",
        "Anti-Myeloperoxidase (MPO) ELISA IgG"
    ],
    "Submitter Information": "EUROIMMUN US, LLC",
    "510(k) Number": "k060700",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MOB"
    ],
    "Summary Letter Date": "March 10, 2006",
    "Summary Letter Received Date": "March 15, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple Autoantibodies Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "anti-Proteinase 3 antibodies (PR3)",
        "anti-Myeloperoxidase antibodies (MPO)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "ELISA"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test kit"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN ELISA kits for anti-PR3 and anti-MPO antibody detection in serum and plasma for autoimmune vasculitides diagnosis.",
    "Indications for Use Summary": "Used to determine anti-PR3 or anti-MPO antibodies in human serum and plasma as an aid in the differential diagnosis of Wegener's granulomatosis, microscopic polyangitis, Churg-Strauss syndrome, and other autoimmune vasculitides, alongside other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}